- $1.5 BnWorld market, 2023
- $5.4 BnProjected, 2033
- 13.6%Growth a year (CAGR)
- 1,850Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$630 Mn
11.6% a year · 42% of the world -
2
China
$121 Mn
15.1% a year · 8% of the world -
3
Canada
$120 Mn
13.6% a year · 8% of the world -
4
Japan
$93 Mn
14.1% a year · 6.2% of the world -
5
Germany
$55 Mn
11.8% a year · 3.7% of the world -
6
France
$41 Mn
12.6% a year · 2.8% of the world -
7
UK
$39 Mn
11.6% a year · 2.6% of the world -
8
Brazil
$38 Mn
14.6% a year · 2.5% of the world -
9
Italy
$36 Mn
13.1% a year · 2.4% of the world -
10
Ecuador
$30 Mn
14.2% a year · 2% of the world
Most clinical trials
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)
AustraliaBrain Cancer Diagnostic by country and region
Spain
India
Saudi Arabia
Mexico
South Africa
UAE
Egypt
Philippines
Hong Kong
Malaysia
Singapore
Thailand
Kenya
New Zealand
Russia"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 19,668 papers since 2021
- Peritoneal metastasis of histone 3 lysine 27-to-methionine-mutant diffuse midline glioma via ventriculoperitoneal shunt: laparoscopic confirmation of occult disease and the need for multimodal liquid biopsy. BMJ case reports, 2026
- Liquid biopsy for brain tumors. Current opinion in neurology, 2026
- Isocitrate dehydrogenase-mutant glioma in the post-INDIGO era: advances in classification and management. Current opinion in neurology, 2026
- Mapping intratumoral heterogeneity in adolescent CNS tumors using simultaneous amide proton transfer-weighted signal and (18)F-choline PET: A feasibility study. Neuro-oncology advances, 2026
- Clinically Suspected Tumefactive Demyelination Mimicking a Brain Tumor in a 10-Year-Old Boy: A Case Report. Clinical case reports, 2026
Compare Brain Cancer Diagnostic side by side
Key companies in Brain Cancer Diagnostic
F. Hoffmann-La Roche Ltd
Thermo Fisher Scientific Inc.
Illumina Inc.
GE Healthcare
Becton, Dickinson and Company
bioMérieux SA
Siemens Healthineers
Philips Healthcare
Agilent Technologies
Quick answers
How big is the Brain Cancer Diagnostic market?
The world Brain Cancer Diagnostic market was worth about $1.5 Bn in 2023 and is projected to reach $5.4 Bn by 2033, growing 13.6% a year (CAGR).
Which country has the largest Brain Cancer Diagnostic market?
The US is the largest of the 24 countries we cover, at $630 Mn in 2023. India grows fastest, at 16.6% a year.
How many clinical trials are running in Brain Cancer Diagnostic?
ClinicalTrials.gov lists 1,850 active trials worldwide (recruiting, about to start or running), most of them in the US, as of 10 Nov 2026.
How much research is published on Brain Cancer Diagnostic?
PubMed lists about 19,668 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.